NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0660
0.00 (0.00%)
Jun 13, 2025, 2:42 PM AEST

ASX:NSB Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2016 - 2019
Market Capitalization
10611264815
Upgrade
Market Cap Growth
-25.00%-49.60%-55.56%-46.27%222.72%39.59%
Upgrade
Enterprise Value
528164311
Upgrade
Last Close Price
0.070.040.080.180.340.19
Upgrade
PE Ratio
8.1417.84----
Upgrade
PS Ratio
4.312.622.32-50.13-
Upgrade
PB Ratio
1.921.082.444.683.294.08
Upgrade
P/TBV Ratio
2.061.172.604.973.384.62
Upgrade
P/FCF Ratio
-136.31----
Upgrade
P/OCF Ratio
8.25130.72----
Upgrade
EV/Sales Ratio
2.281.111.65-44.93-
Upgrade
EV/EBITDA Ratio
4.599.93----
Upgrade
EV/EBIT Ratio
5.0215.76----
Upgrade
EV/FCF Ratio
-57.68----
Upgrade
Asset Turnover
0.500.410.76-0.10-
Upgrade
Quick Ratio
175.6958.468.303.3163.6137.34
Upgrade
Current Ratio
179.3058.878.393.3464.5837.34
Upgrade
Return on Equity (ROE)
27.00%6.46%-20.93%-103.71%-34.82%-65.87%
Upgrade
Return on Assets (ROA)
14.08%1.81%-11.24%-58.19%-21.98%-41.49%
Upgrade
Return on Capital (ROIC)
14.31%1.93%-14.34%-65.25%-22.36%-42.21%
Upgrade
Return on Capital Employed (ROCE)
20.20%2.90%----
Upgrade
Earnings Yield
12.44%5.61%-9.31%-40.41%-6.61%-19.26%
Upgrade
FCF Yield
-0.73%-20.08%-26.90%-5.47%-15.33%
Upgrade
Buyback Yield / Dilution
-1.15%-0.72%---83.04%-9.59%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.